National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
76.62
-0.53 (-0.69%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Company Description

National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical facility investments.

NHI's portfolio consists of independent living facilities, assisted living and memory care communities, entrance-fee retirement communities, senior living campuses, skilled nursing facilities and specialty hospitals.

National Health Investors, Inc. was established on October 15th 1991 and was incorported in 1991 in Maryland, USA.

National Health Investors, Inc.
National Health Investors logo
Country United States
Founded 1991
IPO Date Oct 9, 1991
Industry REIT - Healthcare Facilities
Sector Real Estate
Employees 32
CEO D. Mendelsohn

Contact Details

Address:
222 Robert Rose Drive
Murfreesboro, Tennessee 37129-6346
United States
Phone 615 890 9100
Website nhireit.com

Stock Details

Ticker Symbol NHI
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000877860
CUSIP Number 63633D104
ISIN Number US63633D1046
Employer ID 62-1470956
SIC Code 6798

Key Executives

Name Position
D. Eric Mendelsohn President, Chief Executive Officer and Director
John L. Spaid Executive Vice President of Finance, Chief Financial Officer and Treasurer
Kevin Carlton Pascoe Executive Vice President of Investments and Chief Investment Officer
David Louis Travis Senior Vice President and Chief Accounting Officer
Kristin Sallee Gaines Senior Vice President and Chief Transaction Officer
Dana Rolfson Hambly Vice President of Finance and Investor Relations
Kimberly Ouimet Director of Corporate Compliance and Human Resources
Beth J. Blankenship Senior Vice President of Legal Affairs and Corporate Secretary
Grant Johnston Senior Vice President Asset Management
Susan V. Sidwell Corporate Secretary

Latest SEC Filings

Date Type Title
Apr 23, 2026 8-K Current Report
Apr 22, 2026 8-K/A [Amend] Current report
Apr 21, 2026 8-K Current Report
Apr 3, 2026 ARS Filing
Apr 3, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 3, 2026 DEF 14A Other definitive proxy statements
Mar 27, 2026 SCHEDULE 13G/A Filing
Mar 16, 2026 8-K Current Report
Mar 16, 2026 424B5 Filing
Mar 16, 2026 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers